Académique Documents
Professionnel Documents
Culture Documents
ENTERAL
FEEDING
FORMULA
Michele Port, P.Dt.
Clinical Dietitian
March 2014
LEARNING OBJECTIVES
1. Identify common sources of protein, carbohydrate and fat used in enteral
feeding formulas.
2. Identity formulas which could benefit your patient population and to include
in your formulary.
3. Become familiar with high protein formulas and modular products.
OUTLINE
Introduction
Formula composition
Types of feedings
Enteral formulary
Case study
Conclusion
INTRODUCTION
Choice of an enteral formula depends on several factors.
You need to complete your nutrition assessment and calculate your
patients nutritional requirements before deciding on an appropriate
formula. Formulas from different companies are often similar.
The decision of which formulas to include in a formulary comes down
CHOICE of an ENTERAL
FORMULA
Depends on:
Nutritional requirements: calories, protein, other
GI symptoms? Ex.: GERD, gastroparesis, bowel motility.
Digestion and absorption intact? Does the
patient have history of IBD, high ileostomy output,
bowel
resections ?
Organ dysfunction or specific disease state
Ex.: renal failure on dialysis.
Fluid restriction.
Viscosity of formula.
Cost.
Format: Closed versus Open system.
CHOICE of an ENTERAL
FORMULA
FORMULA COMPOSITION
FORMULA COMPOSITION
CARBOHYDRATE
Primary energy source in most enteral formulas.
Usually 40%-90% of total calories
SOURCE of CARBOHYDRATE
Polymeric
Elemental / Semi-Elemental
Corn Starch
Maltodextrin
Maltodextrin
Sucrose
Fructose
Fructose
FORMULA COMPOSITION
PROTEIN
Source of nitrogen and energy
In enteral formulas:
i.
ii.
FORMULA COMPOSITION
FAT
Concentrated source of energy
Source of essential fatty acids (linoleic and linolenic acid)
Medium chain triglycerides (MCT) do not contain essential fatty
acids
FAT SOURCE
Polymeric
Elemental / Semi-Elemental
Safflower Oil
Fish Oil
Coconut Oil
Soybean Oil
Sardine Oil
Canola Oil
Menhaden Oil
Soybean Oil
Corn Oil
Coconut Oil
Safflower Oil
Borage Oil
Soy Lecithin
Fish Oil
Soy Lecithin
Fish Oil
Structured Lipids
FORMULA COMPOSITION
FAT
MCT:
FORMULA COMPOSITION
FORMULA COMPOSITION
WATER
Usually 70%-80% of formula
Need to include water in formula in total fluid intake
ELECTROLYTES
Most formulas contain adequate amounts
Hepatic formula very low in sodium
TYPES OF FORMULAS
POLYMERIC
1. Standard (Ex.: Osmolite 1 CAL)
29%
Carbohydrate
54%
Protein
17%
Fat
29%
Isosource VHP
Promote
Carbohydrate
50%
45%
52%
Protein
25%
25%
25%
Fat
25%
30%
23%
TYPES OF FORMULAS
POLYMERIC
2. High Protein (Ex.: Isosource VHN, Isosource VHP, Promote)
20%-25% Protein
Indications:
Catabolism
Wound healing
Pressure ulcers
Patients on propofol
Plasmapheresis
CVVHD - continuous dialysis
Burn patients
TYPES OF FORMULAS
POLYMERIC
3. Energy Dense: (Ex.: Nutren 1.5, Nutren 2.0, Resource 2.0, Two Cal HN)
Provide 1.5-2 Kcal / mL
Indications:
Fluid restriction
CHF
Renal failure
Ascites
Hyponatremic (hypervolemic)
4. Commercial blenderized food product (Ex.: Compleat) made from pureed
foods (chicken, fruit vegetable, juice, etc)
Formula is very well tolerated but very viscous
FORMULA COMPOSITION
POLYMERIC
5. Fibre
Fibre-containing formula (Ex.: Jevity, Jevity 1.5, Isosource 1.5,
Isosource VHN, Isosource HN Fibre) combination of soluble
and insoluble fibre:
Promoted to maintain bowel regularity:
Prevent constipation in long term EN
Decrease diarrhea in short term EN
Combination of soluble and insoluble fibre:
Soluble fibre: Fermented to SCFA in colon by bacteria,
promotes sodium and water absorption
Insoluble fibre: Increases fecal weight / bulk
FORMULA COMPOSITION
POLYMERIC
5. Fibre
Need adequate amounts of fluid to prevent constipation
and impaction / obstruction
Avoid fibre in hypotensive patients - high risk for developing
ischemic bowel
McClave et al. JPEN 2009; 33:27
FORMULA COMPOSITION
POLYMERIC
6. Prebiotics
Prebiotics are:
Resistant to gastric acidity and digestion
Fermented by GIT endogenous microbiome
Stimulate growth of intestinal microbiota which contains
health benefits
Examples:
Inulin (chicory, leeks, onions, garlic)
Inulin type fructans (oligo fructose or fructo oligo
saccharides)
Lactulose
FORMULA COMPOSITION
POLYMERIC
6. Prebiotics
FOS added to some enteral formulas suh as Jevity 1.2,
Jevity 1.5, Nepro with carb steady, Two Cal HN, Peptamen AF,
Peptamen
Fermented by bacteria in colon to SCFAs which stimulate growth
of beneficial bacteria in colon and stimulate water and electrolyte
absorption
FORMULA COMPOSITION
ELEMENTAL / SEMI-ELEMENTAL
Designed
If
FORMULA COMPOSITION
DISEASE SPECIFIC
1. RENAL
Dialysis Patients (Intermittent Hemodialysis)
Ex.: Nepro, NovaSource Renal
Energy dense: 2 Kcal / ml
Low in K+ and phosphorus
Protein content increased to 18% by manufacturers so it can
be used for AKI
High fat (majority of fat long chain FA) with concern in patients
with gastroparesis and pancreatic insufficiency
FORMULA COMPOSITION
DISEASE SPECIFIC
1. RENAL
Predialysis patients. Ex.: Suplena
Calorie dense 2 Kcal / mL
Low protein: 30g protein / litre
Low K and phosphorus
High fat: 96g / litre
FORMULA COMPOSITION
DISEASE SPECIFIC
2. HEPATIC Ex.: NutriHep
Energy dense: 1.5 Kcal / mL
Increased branch-chained amino acids
Decreased aromatic amino acids
Semi-elemental:
FORMULA COMPOSITION
DISEASE SPECIFIC
3. DIABETIC Ex.: Glucerna, Resource Diabetic
Low Carbohydrate 34%-36%
17%-20% protein
High fat (> 40%)
Contains fibre
May not be well tolerated with diabetic gastroparesis
Indication:
Hyperglycemia, patients on corticosteroids
Optimize glycemia with insulin protocol prior to using this product
FORMULA COMPOSITION
DISEASE SPECIFIC
4. PULMONARY Ex.: Oxepa, for ALI and ARDS
High in fat: 55% (contains fish oil)
Omega-3 to Omega-6 ratio
Supplemented with antioxidants (Vit E, Vit C and beta-carotene)
FORMULA COMPOSITION
DISEASE SPECIFIC
5. IMMUNE-ENHANCING FORMULA Ex.: Impact, Peptamen AF, Oxepa
Formulas contain one or more of the following: glutamine,
arginine, Omega-3 FA, nucleotides and antioxidants.
Oxepa and Peptamen AF are very high in Vitamin A content,
need to take this into consideration if tube feeding a pregnant
woman.
In critically-ill, arginine and glutamine should not be
supplemented
MODULAR PRODUCTS
1. PROTEIN Ex.: Beneprotein powder
Whey protein
6g protein / scoop 7 g
Provides 25 Kcal / scoop
Relatively low in K, phos but must be considered if using a large
number of scoops
Mixes easily with water
Useful to supplement formulas when protein requirement is 2g / kg
Liquid protein supplements exist but are not availbale in Canada
MODULAR PRODUCTS
2. CARBOHYDRATE Ex.: Polycose
Glucose powder mixed with water or beverages to increase calories
malabsorption
120 Kcal / tbsp
Case Study
56 yo male Lt. vertebral artery dissection and basilar artery thrombosis after neck
manipulation by a chiropractor in 2010. Tracheostomy and PEG placed in 2010 and pt was
transferred to a long term care hospital.
July 2011:
albumin
On Peptamen 1.5 enteral feeding via PEG due to intolerance of other formulas
Case Study
Diarrhea resolved, pressure ulcers started healing, weaned from ventilator. Transferred
to medical ward November 2011.
July 2012: returned to ICU with respiratory failure, hypersalivation, blackspots in PEG.
Case Study
Case Study
August 1:
no leak.
Case Study
Aspiration?
No BM August 3-7
Enema given
Case Study
Recommend PEG/J
Case Study
Changed formula to Isosource 1.5 with 7g fibre / litre (soy fibre and
guargum)
Case Study
Bloating
Case Study
Gastroenterologist consulted
Recommended high fibre high fat diabetic formula (12g soy fibre / litre,
40% calories as fat)
Wife believes pt had candida in stomach and is bloated for this reason
Ongoing bloating
Ongoing bloating with diabetic formula but BM q 2-3 days with laxatives
and stool softener
Case Study
Agrees to trial
Case Study
References
Abbott Nutrition. Adult Nutritional products Guide. Dec. 2008.
Boullata J, Nieman Carney L, Guenter P, eds. Enteral formula selection and preparation.
In: A.S.P.E.N. Enteral Nutrition Handbook, Silver Spring, MD: American Society for
Parenteral and Enteral Nutriiton; 2010: 91-157.
Chen Y, Peterson SJ. Enteral feeding formulas: which formula is right for your adult patient?
Nutr Clin Pract. 2009; 24: 344-355.
DeChicco RS, Materese LE. Determining the nutrition support regimen. In: Matarese L, Gottschlich M,
eds. Comtemporary Nutrition Support Practice. Philadelphia, Pennsylvania: WB. Saunders Co.,
1998; 185-191.
Lefton J, Halasa Esper D, Kochevar M. Enteral formulations. In: Gottschlich Met al., eds.
The
A.S.P.E.N. Nutrition Support Care Curriculum. Silver Spring, MD; American Society for Parenteral
and Enteral Nutrition; 2007: 209-232.
Nestl Health Science. Healthcare Nutrition Product Guide 2013-2014. Sept 2013.
Winge K, Rasmussen D, Werdelin LM. Constipation in neurologiocal disease.
J Neurol Neurosurg Psychiatry 2003; 74: 13-19.
THANK YOU